You searched for Corporate

01 Avril 2026 - 1 min read

Our 2025 Sustainability Statement is Live: Here’s What It Means for Ipsen

We are pleased to announce that Ipsen’s 2025 Sustainability Statement - our annual publication outlining Ipsen’s environmental, social and governance (ESG) commitments, progress and priorities - is now available on our website, reflecting our commitmen...

- 06 Juin 2024

Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer

PARIS, FRANCE, 06 June 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven biopharmaceutical company, announced today the appointment of Josep Catllà as EVP, Chief Corporate Affairs Officer, effective August 19, 2024. He will serve on...

- 01 Avril 2026 - 1 min read

Notre Sustainability Statement 2025 est en ligne : ce que ça signifie pour Ipsen

Nous avons le plaisir d’annoncer que le Sustainability Statement 2025 - notre publication annuelle présentant nos engagements, nos avancées et nos priorités en matière d’environnement, de social et de gouvernance (ESG) - est désormais disponible s...

- 12 Janvier 2026 - 2 mn de lecture

Bridging science and leadership: Elisabetta Leo on guiding early development at Ipsen

“I felt, during my career path, that I was more a scientist rather than a leader; in my current role, I’m bridging the two as a research leader.” ...

- 01 Octobre 2024 - 1 min read

Ipsen Achieves Its Record-High Score in 2024 S&P Global CSA, Setting New Company Benchmark

....

- 27 Février 2026 - 2 mn de lecture

Listening isn’t a slogan, it’s the foundation of rare disease care

By Josep Catlla, EVP, Corporate Affairs Officer, Ipsen...

- 06 Juin 2024

Ipsen nomme Josep Catllà, en qualité de Vice-Président Exécutif, Chief Corporate Affairs Officer

PARIS, FRANCE, 06 juin 2024 - Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique mondial de spécialité, annonce aujourd’hui la nomination de Josep Catllà en tant que Vice-Président Exécutif, Chief Corporate Affairs Officer, à compter du...

- 18 Septembre 2025 - 3 mn de lecture

PBC Awareness Day: Confronting Bias and Elevating Patient Voices

...

- 06 Mai 2025

Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation

PARIS, FRANCE, 06 May 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven biopharmaceutical company, announced today the appointment of Laura Réveillon, PhD as EVP, Strategy & Transformation, effective May 14, 2025. She will se...

- 12 Mai 2023

Corporate News

...

1 2 3 … 53

Résultats de recherche